Tonix Pharmaceuticals Holding Corp
For the period ended Mar 31, 2025. Filed May 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2C. Purchases of Equity Securities
The following table shows the activity related to our share repurchase program for the three months ended March 31, 2025:
| TotalNumberof SharesPurchased | AveragePrice PaidPer Share | Total Numberof SharesPurchased asPart ofPubliclyAnnouncedPlans orPrograms(1) | MaximumNumber (orApproximateDollar Value)of Shares thatMay Yet bePurchasedUnder thePlans orPrograms | |
|---|---|---|---|---|
| September 2024 Program | ||||
| January 1 through January 31, 2025 | — | $— | — | $— |
| February 1 through February 28, 2025 | — | — | — | — |
| March 1 through March 31, 2025 | 250,000 | 12.15 | 250,000 | $6,961,325 |
| First Quarter Total | 250,000 | $12.15 | 250,000 | $6,961,325 |
(1) On September 6, 2024, the Board of Directors approved a share repurchase program pursuant to which the Company may purchase up to $10.0 million in value of its outstanding common stock from time to time on the open market and in privately negotiated transactions subject to market conditions, share price and other factors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.